Cubist Systematic Strategies, LLC Intra Cellular Therapies, Inc. Transaction History
Cubist Systematic Strategies, LLC
- $15.8 Billion
- Q3 2024
A detailed history of Cubist Systematic Strategies, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 120,762 shares of ITCI stock, worth $10.6 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
120,762
Previous 95,071
27.02%
Holding current value
$10.6 Million
Previous $6.51 Million
35.62%
% of portfolio
0.06%
Previous 0.05%
Shares
27 transactions
Others Institutions Holding ITCI
# of Institutions
377Shares Held
85MCall Options Held
299KPut Options Held
130K-
Vanguard Group Inc Valley Forge, PA9.63MShares$844 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$554 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.29MShares$463 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.85MShares$337 Million1.4% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.05MShares$267 Million3.36% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $8.27B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...